Financial statements Syngenta Polska
Balance sheet data of SYNGENTA POLSKA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 261 974 359,72 | 245 404 087,44 | 423 698 907,13 | 328 078 616,63 | 467 203 828,01 | 436 934 323,51 |
| A. Fixed assets | 14 531 394,30 | 13 369 475,56 | 12 455 034,08 | 13 228 766,95 | 15 484 048,81 | 19 462 953,55 |
| B. Current assets | 247 442 965,42 | 232 034 611,88 | 411 243 873,05 | 314 849 849,68 | 451 719 779,20 | 417 471 369,96 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 261 974 359,72 | 245 404 087,44 | 423 698 907,13 | 328 078 616,63 | 467 203 828,01 | 436 934 323,51 |
| A. Equity | 75 599 622,07 | 80 454 389,41 | 92 211 879,99 | 104 484 268,78 | 119 463 016,92 | 132 468 747,79 |
| B. Liabilities and provisions for liabilities | 186 374 737,65 | 164 949 698,03 | 331 487 027,14 | 223 594 347,85 | 347 740 811,09 | 304 465 575,72 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 161 544 486,05 | 133 052 694,83 | 295 775 297,40 | 183 307 146,35 | 291 401 099,58 | 254 964 972,75 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.